Erector Spinae Plane Block in Uniportal VATS
ESPB-UVATS
Effectiveness of Erector Spinae Plane Block in Uniportal VATS Lung Resections
ESPB-UVATS
Effectiveness of Erector Spinae Plane Block in Uniportal VATS Lung Resections
Sponsor study identifier
observational
75
1 country
1
Study Start
January 1, 2022
Actual (reported)Primary Completion
May 30, 2023
Actual (reported)Study Completion
December 20, 2023
Actual (reported)The main aim of this study is to compare the effectiveness of three alternative techniques (continuous Erectus Spinae Plane Block : c-ESPB; continuous Serratus Anterior Plane Block : c-SAPB; and Intercostal Nerve Block: ICNB) in reducing the severity of early postoperative pain after Uniportal-VATS lung resections. Primary outcomes will be opioid and other analgesic drugs consumption in the 72 hours after surgery, and static and dynamic pain scores, measured by the visual analog scale (VAS), at 6 pre-established time-points during the first 48 hours postoperatively. Further outcomes will be incidence of pulmonary and cardiac complications until patient's discharging, pain when removing drains, presence/absence of chronic neuropathic pain (12 weeks after surgery).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 20, 2023
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 10, 2021
Actual (reported)May 19, 2021
Actual (reported)January 1, 2022
Actual (reported)May 30, 2023
Actual (reported)December 20, 2023
Actual (reported)analgesic drug consumption
number of doses of analgesic drugs administered on patients' request during the postoperative period
first 72 hours after extubation
severity of early postoperative pain
static and dynamic pain scores, measured by the visual analog scale (VAS), at 6 pre-established time-points during the first 48 hours postoperatively.
first 48 hours after extubation
respiratory and cardiac complications
first 72 hours after extubation
Postoperative analgesia ensured by continuous ultrasound-guided ESPB performed at the end of surgery.
Postoperative analgesia ensured by continuous SAPB performed by surgeons at the end of surgery.
Postoperative analgesia ensured by "one-shot" ICNB + continuous intravenous administration of tramadol by elastomeric pump.
In the c-ESPB group an ultrasound-guided ESPB will be performed by the attending anaesthesiologist at the end of surgery, immediately after the last surgical stitch and before extubation. After an initial bolus of 20 ml 0,2% ropivacaine, a catheter will be left in place into the fascial plane deep to the erector spinae muscle to ensure continuous infusion (5ml/h for 48 hours) of the local anesthetic.
In the c-SAPB group SAPB will be performed by surgeons intraoperatively, immediately before the closure of chest wall muscle planes, by injection of 20 ml 0,2% ropivacaine into the fascial plane above the Serratus Anterior muscle. After the initial bolus, a catheter will be left in place into the superficial fascial plane of the Serratus Anterior muscle to ensure continuous infusion (5ml/h for 48 hours) of the local anesthetic.
Adults patients (age \> 18 years) scheduled for Uniportal-VATS lung resections, regardless of whether for benign or malignant disease and for any type of lung resection (segmentectomy, lobectomy, atypical lung resection).
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, 00168, Italy
Dania Nachira, MD
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Giovanni Punzo, MD
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
75 participants (actual enrollment reported by the registry).
First Submitted
May 10, 2021
First Posted
May 19, 2021
Study Start
January 1, 2022
Actual (reported)pain at drain removal
chest drain removal (third/fourth postoperative day)
incidence of chronic pain
12 weeks after surgery
In the ICNB-group ICNB will be performed by surgeons intraoperatively, immediately before chest drain placement, by injection of 20 ml of 0,2% ropivacaine into the intercostal spaces (III-VII), below the parietal pleura, under direct visualization of the neurovascular bundle. The "one-shot" ICNB will be associated in this group with intravenous administration of tramadol (300 mg/48 h) by elastomeric pump.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
May 30, 2023
Actual (reported)Study Completion
December 20, 2023
Actual (reported)Last Updated
August 15, 2025
Record last verified: 2023-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: